{"id":61440,"date":"2025-06-17T16:02:56","date_gmt":"2025-06-17T14:02:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/"},"modified":"2025-06-17T16:02:56","modified_gmt":"2025-06-17T14:02:56","slug":"erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/","title":{"rendered":"Erlanger and Qventus Partner to Expand Robotic Access and Create Additional OR Capacity"},"content":{"rendered":"
\n

\nQventus\u2019 Surgical Growth Solution Modernizes Operations and Alleviates the Administrative Burden on Care Teams for Leading Tennessee-Based Healthcare System<\/i><\/p>\n

NEW YORK–(BUSINESS WIRE)–Erlanger<\/a>, a nationally-acclaimed, multi-hospital health system, announced today a strategic partnership with Qventus<\/a>, the industry\u2019s premier provider of AI-based care operations automation software, to drive strategic surgical growth and increase patient access to the most advanced, minimally invasive da Vinci procedures. This investment in Qventus\u2019 Surgical Growth Solution is part of Erlanger\u2019s commitment to leveraging the latest AI technology and best-in-class tools to serve more patients, streamline operations, and better support dedicated staff.<\/p>\n

<\/a>
<\/a><\/p>\n

\nHealth systems across the U.S. face immense operational inefficiencies that shrink already thin margins which are required to deliver exceptional care to patients. Surgery is a key revenue driver where every percentage of growth can represent millions of dollars of impact, yet 30% of OR time goes unused. Erlanger selected Qventus\u2019 Surgical Growth Solution to drive strategic growth, turning Erlanger\u2019s ambitious goals into action by filling ORs with high-value cases, maximizing robotics investments, and strengthening referral patterns with one-of-a-kind market insights.<\/p>\n

\n\u201cAt Erlanger, we are always seeking ways to do more for our community and our staff,\u201d said Misti Mattox, Vice President of Surgical Services at Erlanger. \u201cQventus\u2019 AI technology goes beyond a simple scheduling tool\u2014it\u2019s a complete solution that fills every white space with the best-fit surgeon and case. This means our clinicians can focus more on patient care and less on administrative tasks, while our community gains access to the very best in healthcare.\u201d<\/p>\n

\nQventus\u2019 suite of AI teammates works 24\/7 to deliver a seamless, white-glove experience to surgeons and clinic schedulers. Machine learning algorithms are personalized to surgeon preferences and behavior patterns, intelligently matching open OR slots with the right surgeons, eliminating first-come, first-served inefficiencies and prioritizing high-value cases.<\/p>\n

\n\u201cForward-thinking organizations like Erlanger have all of the specialists, staff, OR space, and robotic assets to deliver exceptional care but it\u2019s nearly impossible to maximize all of those resources with the outdated technology that most health systems in the U.S. rely on,\u201d said Mudit Garg, CEO, Qventus. \u201cOur Surgical Growth Solution was developed in close partnership with hospital leaders and providers who grapple with these challenges daily. With Erlanger as a new strategic partner, we can continue to evolve and refine our suite of AI teammates to best serve their specific patient needs.\u201d<\/p>\n

\nQventus\u2019 Surgical Growth Solution delivers an average 11X ROI for its health system partners. Ardent Health achieved 41% growth in robotics volume and West Tennessee Healthcare added a record 61 cases to its schedule in the first 100 days of Qventus thanks to streamlined booking for independent surgeons and clinic schedulers. Allina Health, one of the nation\u2019s largest nonprofit health systems, added over 50 robotic cases in the last quarter of 2024, resulting in a $5.8 million Qventus-affected contribution margin.<\/p>\n

\nAbout Qventus<\/p>\n

\nQventus uses AI to intelligently automate operations across care settings to help health systems secure the margins needed to achieve their mission of delivering exceptional care to patients in their communities. Leveraged by more than 150 hospital facilities, Qventus\u2019 enterprise platform and AI solution suite reduce the administrative burden, identify potential issues upstream, surface suggested interventions, and actually take action to solve problems for busy healthcare staff\u2014a collective system of action that sits on top of a hospital\u2019s enterprise systems of record. Qventus unlocks best-in-industry ROI by driving strategic surgical growth, creating capacity, and reducing costs, all while delivering powerful insights to help solve long standing operational challenges once and for all. 100% of clients say they consider Qventus part of their long term strategy. Learn more at www.qventus.com<\/a>.<\/p>\n

\nAbout Erlanger<\/p>\n

\nErlanger is a non-profit health system based in Chattanooga, Tenn., affiliated with the University of Tennessee Health Science Center College of Medicine. The seven-hospital system includes the region\u2019s only Level I Trauma Center, children\u2019s hospital, Level IV NICU, kidney transplant center, 24\/7 stroke care, and many more essential services. Children\u2019s Hospital at Erlanger provides the highest level of trauma, critical, and inpatient care. Erlanger is the sole provider of tertiary care services spanning a 50,000 square-mile region encompassing southeast Tennessee, northwest Georgia, north Alabama, and western North Carolina. The health system comprises seven hospitals and emergency departments, provides medical services for a fleet of six helicopters, and offers exceptional, comprehensive care at all of life\u2019s stages. With a history of over a century, Erlanger continues its founding mission to compassionately care for people. Visit www.erlanger.org<\/a><\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact<\/b>
qventus@solcomms.co<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Qventus\u2019 Surgical Growth Solution Modernizes Operations and Alleviates the Administrative Burden on Care Teams for Leading Tennessee-Based Healthcare System NEW YORK–(BUSINESS WIRE)–Erlanger, a nationally-acclaimed, multi-hospital health system, announced today a strategic partnership with Qventus, the industry\u2019s premier provider of AI-based care operations automation software, to drive strategic surgical growth and increase patient access to the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61440","6":"format-standard","7":"category-industry"},"yoast_head":"\nErlanger and Qventus Partner to Expand Robotic Access and Create Additional OR Capacity - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Erlanger and Qventus Partner to Expand Robotic Access and Create Additional OR Capacity - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Qventus\u2019 Surgical Growth Solution Modernizes Operations and Alleviates the Administrative Burden on Care Teams for Leading Tennessee-Based Healthcare System NEW YORK–(BUSINESS WIRE)–Erlanger, a nationally-acclaimed, multi-hospital health system, announced today a strategic partnership with Qventus, the industry\u2019s premier provider of AI-based care operations automation software, to drive strategic surgical growth and increase patient access to the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-17T14:02:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250617272367\/en\/2499163\/22\/Qventus-logo-rgb.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Erlanger and Qventus Partner to Expand Robotic Access and Create Additional OR Capacity\",\"datePublished\":\"2025-06-17T14:02:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\\\/\"},\"wordCount\":765,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250617272367\\\/en\\\/2499163\\\/22\\\/Qventus-logo-rgb.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\\\/\",\"name\":\"Erlanger and Qventus Partner to Expand Robotic Access and Create Additional OR Capacity - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250617272367\\\/en\\\/2499163\\\/22\\\/Qventus-logo-rgb.jpg\",\"datePublished\":\"2025-06-17T14:02:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250617272367\\\/en\\\/2499163\\\/22\\\/Qventus-logo-rgb.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250617272367\\\/en\\\/2499163\\\/22\\\/Qventus-logo-rgb.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Erlanger and Qventus Partner to Expand Robotic Access and Create Additional OR Capacity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Erlanger and Qventus Partner to Expand Robotic Access and Create Additional OR Capacity - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/","og_locale":"en_US","og_type":"article","og_title":"Erlanger and Qventus Partner to Expand Robotic Access and Create Additional OR Capacity - Pharma Trend","og_description":"Qventus\u2019 Surgical Growth Solution Modernizes Operations and Alleviates the Administrative Burden on Care Teams for Leading Tennessee-Based Healthcare System NEW YORK–(BUSINESS WIRE)–Erlanger, a nationally-acclaimed, multi-hospital health system, announced today a strategic partnership with Qventus, the industry\u2019s premier provider of AI-based care operations automation software, to drive strategic surgical growth and increase patient access to the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/","og_site_name":"Pharma Trend","article_published_time":"2025-06-17T14:02:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250617272367\/en\/2499163\/22\/Qventus-logo-rgb.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Erlanger and Qventus Partner to Expand Robotic Access and Create Additional OR Capacity","datePublished":"2025-06-17T14:02:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/"},"wordCount":765,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250617272367\/en\/2499163\/22\/Qventus-logo-rgb.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/","url":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/","name":"Erlanger and Qventus Partner to Expand Robotic Access and Create Additional OR Capacity - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250617272367\/en\/2499163\/22\/Qventus-logo-rgb.jpg","datePublished":"2025-06-17T14:02:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250617272367\/en\/2499163\/22\/Qventus-logo-rgb.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250617272367\/en\/2499163\/22\/Qventus-logo-rgb.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Erlanger and Qventus Partner to Expand Robotic Access and Create Additional OR Capacity"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61440"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61440\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}